APA (7th ed.) Citation

Hong Li, Dan Song, Qihui Liu, Linlin Li, Xiaoshi Sun, Jiamei Guo, . . . Ping Li. (2022). miR-351 promotes atherosclerosis in diabetes by inhibiting the ITGB3/PIK3R1/Akt pathway and induces endothelial cell injury and lipid accumulation. BMC.

Chicago Style (17th ed.) Citation

Hong Li, Dan Song, Qihui Liu, Linlin Li, Xiaoshi Sun, Jiamei Guo, Dianlian Li, and Ping Li. MiR-351 Promotes Atherosclerosis in Diabetes by Inhibiting the ITGB3/PIK3R1/Akt Pathway and Induces Endothelial Cell Injury and Lipid Accumulation. BMC, 2022.

MLA (9th ed.) Citation

Hong Li, et al. MiR-351 Promotes Atherosclerosis in Diabetes by Inhibiting the ITGB3/PIK3R1/Akt Pathway and Induces Endothelial Cell Injury and Lipid Accumulation. BMC, 2022.